Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to DO2010000347ApriorityCriticalpatent/DOP2010000347A/en
Publication of DOP2010000347ApublicationCriticalpatent/DOP2010000347A/en
La invención proporciona los compuestos nombrados de fórmula (I), en la que R4 es una quinuclidina N-sustituida (I). composiciones farmacéuticas que los contienen y un proceso para preparacion las composiciones farmacéuticas. Tambien se divulga su uso en terapia para el tratamiento de afecciones Mediadas por receptores muscarinos M3, tales como la enfermedad pulmonar obstructiva crónica.The invention provides the named compounds of formula (I), wherein R 4 is an N-substituted quinuclidine (I). pharmaceutical compositions containing them and a process for preparing pharmaceutical compositions. Its use is also disclosed in therapy for the treatment of conditions mediated by M3 muscarine receptors, such as chronic obstructive pulmonary disease.
DO2010000347A2010-11-122010-11-12
QUINUCLIDINE DERIVATIVES AS M3 MUSCARINIC RECOVERY ANTAGONISTS
DOP2010000347A
(en)